Sort by:

select Language:

Joint Assessment of the Response to Artemisinin Resistance in the Greater Mekong Sub-Region 

World Health Organization ( WHO), Regional Office for South-East-Asia, (2016)

Conducted November 2011 to February 2012: Summary Report
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackled. Section 4 highlights key achievements and enabling factors for the response to artemisinin resistance, whilst Section 5 provides a more detailed discussion of major issues to be addressed.

Approaches for mobile and migrant populations in the context of malaria multi-drug resistance and malaria elimination in the Greater Mekong Subregion

World Health Organization ( WHO), Regional Office for South-East-Asia, (2016)

The emergence of multifrug-resistant malaria in the Greater Mekong Subregion (‎GMS)‎ has been identified as an emergency issue that may have catastrophic consequences on the future of malaria elimination in the GMS as well as globally. In recognition of the need for a cohesive regional response, GMS countries have committed to a shared goal of eliminating malaria from the GMS by 2030 working within the framework of the Strategy for Malaria Elimination in the Greater Mekong Subregion 2015-2030. Population mobility has been identified as a key concern in the context of multidrug-resistant malaria; and in a region of highly porous borders where the majority of intra-Mekong migration occurs through informal channels, addressing the health needs of migrant populations has never been more critical.

Money and Mosquitoes: The Economics of Malaria in an Age of declining Aid

Eric Maskin, Célestin Monga, Josselin Thuilliez and others, (2018)

(African Development Bank policy research document 1)
The report examines financing in the battle against malaria, focusing on the role of foreign aid. It analyzes whether or not a disease such as malaria can be controlled or eliminated in Africa without health aid. It also presents a theoretical model of the economics of malaria and shows how health aid can help avoid the “disease trap.” While calling for increased funding from international sources to fight malaria, it also recommends that African countries step up their own efforts, including on domestic resource mobilization. In 2016, governments of endemic countries contributed 31% of the estimated total of US $ 2.7 billion.
Between 2000 and 2014, malaria control efforts were scaled up and worldwide deaths were cut in half. But declining health aid and deprioritized vertical aid (as for malaria), despite its potentially great efficiency, have led to rising numbers of cases. In 2016, 216 million cases of malaria were reported, up from 211 million in 2015. Africa was home to 90% of all malaria cases and 91% of malaria deaths in 2016. Progress appears to have stalled in the global fight against the disease.

Lignes directrices unifiées sur le suivi des patients infectés par le VIH et la surveillance des cas selon une approche centrée sur la personne

Organisation mondiale de la Santé (OMS), (2017)

Ces lignes directrices prônent une approche centrée sur la personne des informations stratégiques sur le VIH, ce qui implique de cesser de collecter des données agrégées dans les services (par exemple, le nombre de tests de dépistage du VIH administrés) pour s’intéresser au patient qui reçoit une cascade de services liés entre eux, afin d’améliorer les soins prodigués aux patients et les résultats sanitaires.
Elles réunissent les orientations données en matière de systèmes de suivi des patients et de cas d’infection à VIH dans le cadre du système de surveillance de santé publique. Elles recommandent le recours à un identifiant unique pour le patient, afin d'établir une liaison entre tous les services de santé, ce qui permet de mesurer la cascade de services sur la durée.

Lignes directrices pour la surveillance du VIH chez les femmes enceintes en consultation prénatale à partir des données programmatiques de routine

Eds.: UNAIDS/WHO Working group on global HIV/AIDS and STI surveillance, (2015)

Le présent document s’adresse essentiellement au personnel des programmes de surveillance du VIH dont la tâche est de surveiller l’évolution de l’épidémie de VIH. Il décrit la manière dont les données recueillies systématiquement dans le cadre des programmes de prévention de la transmission mère-enfant du VIH ( PTME) peuvent être utilisées aux fins de la surveillance du VIH chez les femmes enceintes en consultation prénatale.

WHO treatment guidelines for isoniazid-resistant tuberculosis: Supplement to the WHO treatment guidelines for drug-resistant tuberculosis

World Health Organization WHO, (2018)

The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.

Preferred product characteristics for personal protective equipment for the health worker on the frontline responding to viral hemorrhagic fevers in tropical climates

World Health Organization, (2018)

The scope of this PPC document is to serve as a guide to address the unmet public health need for a PPE system that protects the HW-F in tropical climate s while caring for patients and providing heavy duty essential health services. The characteristics described in this guidance are targeted for PPE used in health clinics, hospitals and communities in low resource settings where there is lack of advanced environmental controls and equipment. The purpose is to ensure harmonization in PPE design and its use to avoid confusion and exacerbating the risk of infections in HW-F. The principles of this PPC document can also be considered in risk reduction strategies in other healthcare settings.

328 hits